Iguana Healthcare Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-10,000
Closed -$120K 75
2017
Q1
$120K Buy
10,000
+2,500
+33% +$54.7K 0.06% 69
2016
Q4
$161K Sell
7,500
-29,500
-80% -$1.13M 0.1% 60
2016
Q3
$2.83M Buy
37,000
+19,500
+111% +$1.42M 0.51% 55
2016
Q2
$1.32M Buy
17,500
+2,500
+17% +$201K 0.54% 59
2016
Q1
$1.31M Buy
+15,000
New +$1.31M 0.48% 53

Other funds holding TNDM

Iguana Healthcare Management's TNDM Position: Q2 2017 in Review

Iguana Healthcare Management sold out of Tandem Diabetes Care (TNDM) in Q2 2017, closing a stake of 10,000 shares — an estimated $120K sold.

Iguana Healthcare Management first reported a position in TNDM in Q1 2016 and held it in 5 quarters. The position peaked at $2.83M in Q3 2016. 63 funds tracked by Wall St. Rank hold TNDM as of Q2 2017.

  • Iguana Healthcare Management reported no remaining Tandem Diabetes Care position as of Q2 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 10,000 Tandem Diabetes Care shares in Q2 2017, an estimated $120K.
  • Iguana Healthcare Management first reported a position in Tandem Diabetes Care in Q1 2016 and held it in 5 quarters.
  • Iguana Healthcare Management's Tandem Diabetes Care position peaked at $2.83M in Q3 2016.
  • 63 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2017.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.